AN2 Therapeutics Growth Metrics (2022-2026) | ANTX

Growth Metrics Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) -64.04%25.21%15.99%-18.62%-11.65%-29.03%-9.76%24.55%22.03%41.27%39.82%33.72%30.68%-27.17%
Enterprise Value Growth (3y) (Quarter) -12.61%17.25%17.82%15.98%15.50%1.23%
Enterprise Value (QoQ) (Quarter) -102.11%4.21%7.93%7.97%7.85%-7.60%-30.00%13.38%-6.49%8.47%10.63%10.50%19.78%6.20%1.58%6.40%-47.17%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Assets Growth (3y) (Quarter) 0.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -2637.00-3982.00-2295.00-1001.00-1524.00-1442.00-112.00
Return on Capital Employed Growth (3y) (Quarter) -2556.00368.00
Return on Capital Employed (QoQ) (Quarter) 295.00-578.00-884.00-1471.00-1049.001,109.00409.00491.001,453.00
Return on Equity Growth (1y) (Quarter) -1.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Equity Growth (3y) (Quarter) -1.000.000.000.000.000.00
Return on Equity (QoQ) (Quarter) -1.001.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00